Non-surgical periodontal therapy in patients with poorly controlledtype 2 diabetes and the therapeutic effect of Minocycline on AdvancedGlycation End-Products (AGEs) induced inflammation:a randomized controlled clinical trial

Non-surgical periodontal therapy in patients with poorly controlledtype 2 diabetes and the therapeutic effect of Minocycline on AdvancedGlycation End-Products (AGEs) induced inflammation:a randomized controlled clinical trial

碩士 === 臺北醫學大學 === 牙醫學系碩博士班 === 107

Bibliographic Details
Main Authors:	Ya-Han Chang, 張雅涵
Other Authors:	Hsein-Kun Lu
Format:	Others
Language:	zh-TW
Published:	2019
Online Access:	http://ndltd.ncl.edu.tw/handle/up2dw5

Similar Items

Association between periodontal and systemic inflammation:a study of pro- and anti-inflammatory mediators
by: Norppa, A. (Anna)
Published: (2012)

The therapeutic role of minocycline in Parkinson’s disease
by: Seyda Cankaya, et al.
Published: (2019-03-01)

THE ROLE OF FOOD IN GLYCATION AND LIPOXIDATION OF END PRODUCTSAND – AMPLIFIERS OF INFLAMMATION
by: Stig Bengmark, et al.
Published: (2008-04-01)

Comparative evaluation of locally delivered minocycline and metronidazole in the treatment of periodontitis
by: Nymphea Pandit, et al.
Published: (2013-01-01)

Multiple neuroprotective mechanisms of minocycline in autoimmune CNS inflammation
by: Katharina Maier, et al.
Published: (2007-03-01)

Advanced Glycation End-Products and Their Receptor-Mediated Roles: Inflammation and Oxidative Stress
by: Parisa Younessi, et al.
Published: (2011-09-01)

Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts
by: D.X. Li, et al.
Published: (2014-12-01)

In Vitro Evaluation of Antimicrobial Activity of Minocycline Formulations for Topical Application in Periodontal Therapy
by: Jan-Luca Schmid, et al.
Published: (2020-04-01)

Use of minocycline as systemic antimicrobial therapy in refractory periodontitis with chronic gingival enlargement
by: Parag M Khatri, et al.
Published: (2012-01-01)

Electrosprayed minocycline hydrochloride-loaded microsphere/SAIB hybrid depot for periodontitis treatment
by: Ting Zhang, et al.
Published: (2021-01-01)

Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
by: Kaneko Yuji, et al.
Published: (2009-10-01)

Matrix Metalloproteinases and Minocycline: Therapeutic Avenues for Fragile X Syndrome
by: Saul S. Siller, et al.
Published: (2012-01-01)

Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis
by: Heliang Liu, et al.
Published: (2020-01-01)

Protective Effects of Minocycline in Experimental Gut Inflammation and Injuries in Mouse Models
by: Tien-Yu Huang, et al.
Published: (2009)

Local delivery of minocycline-loaded PEG-PLA nanoparticles for the enhanced treatment of periodontitis in dogs
by: Yao WX, et al.
Published: (2014-08-01)

Glycation and Advanced Glycation End-Products in Laboratory Experiments in Vivo and in Vitro
by: Martin Beránek, et al.
Published: (2006-01-01)

Multiphoton autofluorescence imaging of advanced glycation end products in glycated tissues
by: Lin, Chih-Ju, et al.
Published: (2021)

Multiphoton autofluorescence imaging of advanced glycation end products in glycated tissues
by: Lin, Chih-Ju, et al.
Published: (2021)

Minocycline down-regulates topical mucosal inflammation during the application of microbicide candidates.
by: Liangzhu Li, et al.
Published: (2012-01-01)

Minimum cytocidal effect of different minocycline and doxycycline concentrations to human periodontal ligament fibroblasts in vitro
by: De Wet, Tanya
Published: (2013)

Immunomodulation by Advanced Glycation End-Products
by: Price, Claire
Published: (2009)

The Relationships of the Blood Advanced Glycation End Product Level with the Fragility of Erythrocytes on Type II Ddiabetes
by: Hui-Ya Shen, et al.

Interactions of the Receptor for Advanced Glycation End Products (Rage) with Advanced Glycation End Products (AGEs) and S100B
by: Indurthi, Venkata
Published: (2016)

The association of advanced glycation end products with depression-like in an animal model of mice
by: Yi-Han Chang, et al.
Published: (2016)

Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes
by: Ping Yang, et al.
Published: (2019-01-01)

The role of receptor for advanced glycation end products (RAGE) in cytolethal distending toxin (CDT)-induced inflammation
by: Zhi Pei Jiang, et al.
Published: (2018)

The Effects of Glucose and Advanced Glycation End Products on Inflammation and Angiogenesis in HumanRetinal Pigment Epithelial Cells
by: Liu, Yichun, et al.
Published: (2012)

Minocycline-induced hyperpigmentation
by: Valena Fiscus, et al.
Published: (2014-07-01)

Osseous wound repair under inhibition of the axis of advanced glycation end-products and the advanced glycation end-products receptor
by: Sheng-Chueh Tsai, et al.
Published: (2015-10-01)

Minocycline-Suppression of Early Peripheral Inflammation Reduces Hypoxia-Induced Neonatal Brain Injury
by: Yingjun Min, et al.
Published: (2017-09-01)

Minocycline-loaded calcium polyphosphate glass microspheres as a potential drug-delivery agent for the treatment of periodontitis
by: Iain Gibson, et al.
Published: (2019-07-01)

Minocycline Ointment as a Local Drug Delivery in the Treatment of Generalized Chronic Periodontitis - A Clinical Study
by: Sara Abbas, et al.
Published: (2016-06-01)

Clinical observation of low dose minocycline hydrochloride sustainedrelease agent combined with Vitapex in the treatment of invasive periodontitis
by: Xu Zheng
Published: (2020-01-01)

Development and Evaluation of Minocycline Hydrochloride-Loaded In Situ Cubic Liquid Crystal for Intra-Periodontal Pocket Administration
by: Zhuanzhuan Yang, et al.
Published: (2018-09-01)

Effects of minocycline combined with periocline on the levels of inflammatory factors, ALP and NO in gingival crevicular fluid of patients with periodontitis
by: Xiao-Li Yuan, et al.
Published: (2018-10-01)

Soluble Receptor for Advanced Glycation End Products: A Novel Biomarker for Psoriasis Severity with Therapeutic Implications?
by: Aleksandra Batycka-Baran, et al.
Published: (2018-06-01)

Advanced Glycation End Products in the Pathogenesis of Psoriasis
by: Anastasia Papagrigoraki, et al.
Published: (2017-11-01)

Dietary Advanced Glycation End Products and Aging
by: Karen Chapman-Novakofski, et al.
Published: (2010-12-01)

Targeting of Receptors for Advanced Glycation End-Products (RAGE) Diminishes Acute Secondhand Smoke-Induced Inflammation in Mice
by: Wood, Tyler Thomas
Published: (2014)

Association of dietary advanced glycation end products (AGEs) with inflammation and arterial stiffness in youth with type I diabetes
by: Stucke, Dea
Published: (2020)